SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-17-000061
Filing Date
2017-05-10
Accepted
2017-05-10 16:02:42
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20170331x10q.htm 10-Q 964536
2 EX-10.1 plse-20170331xex10_1.htm EX-10.1 24351
3 EX-31.1 plse-20170331xex31_1.htm EX-31.1 20388
4 EX-31.2 plse-20170331xex31_2.htm EX-31.2 20780
5 EX-32.1 plse-20170331xex32_1.htm EX-32.1 19170
  Complete submission text file 0001562762-17-000061.txt   3480676

Data Files

Seq Description Document Type Size
6 EX-101.INS plse-20170331.xml EX-101.INS 663849
7 EX-101.SCH plse-20170331.xsd EX-101.SCH 23929
8 EX-101.CAL plse-20170331_cal.xml EX-101.CAL 32913
9 EX-101.DEF plse-20170331_def.xml EX-101.DEF 84622
10 EX-101.LAB plse-20170331_lab.xml EX-101.LAB 215281
11 EX-101.PRE plse-20170331_pre.xml EX-101.PRE 177737
Mailing Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010
Business Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010 650-697-3939
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: NV | Fiscal Year End: 1217
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 17830165
SIC: 3841 Surgical & Medical Instruments & Apparatus